ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

ONS Votes to Push Congress on DRGs

June 1, 1984

DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies

March 15, 1985

OCC Has Answers Ready Or Most Questions Asked

March 21, 1980

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979